ID   SJ-DIPGX7c
AC   CVCL_C1NH
SY   SJHGG00101_C2
DR   cancercelllines; CVCL_C1NH
DR   Wikidata; Q114313022
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29956/baker/SJHGG000101/SJ-DIPGX7/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 6.1 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Thr200_Leu201fs (c.600_603delGCCA); Zygosity=Homozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Homozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 17
ST   D21S11: 31,31.2
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 8,11
ST   Penta E: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17-18Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
RX   PubMed=34215733; DOI=10.1038/s41467-021-24168-8; PMCID=PMC8253809;
RA   He C., Xu K., Zhu X.-Y., Dunphy P.S., Gudenas B., Lin W.-W., Twarog N.,
RA   Hover L.D., Kwon C.-H., Kasper L.H., Zhang J.-Y., Li X.-Y., Dalton J.,
RA   Jonchere B., Mercer K.S., Currier D.G., Caufield W., Wang Y.-Z., Xie J.,
RA   Broniscer A., Wetmore C., Upadhyaya S.A., Qaddoumi I., Klimo P.,
RA   Boop F.A., Gajjar A., Zhang J.-H., Orr B.A., Robinson G.W., Monje M.,
RA   Freeman B.B. 3rd, Roussel M.F., Northcott P.A., Chen T.-S., Rankovic Z.,
RA   Wu G., Chiang J.C.-H., Tinkle C.L., Shelat A.A., Baker S.J.;
RT   "Patient-derived models recapitulate heterogeneity of molecular
RT   signatures and drug response in pediatric high-grade glioma.";
RL   Nat. Commun. 12:4089.1-4089.17(2021).
//